Janice A Blalock, Ph.D.
Department of Behavioral Science, Division of Cancer Prevention and Population Sciences
About Dr. Blalock
Janice A. Blalock, Ph.D. is a clinical psychologist with 23 years research experience in treatments for depression and anxiety disorders, and nicotine dependence. Her research area of interest is the development of smoking cessation treatments for smokers with comorbid psychiatric and medical disorders. She has served as a Co-P.I. or PI on a number of NIH grants evaluating smoking cessation interventions in smokers with comorbid psychiatric and health conditions including pregnant women, chronically depressed smokers and cancer patients. She is currently conducting a NIH-funded treatment development study to evaluate Behavioral Activation as depression-focused intervention for pregnant women with major depression. She has published numerous articles evaluating the impact of clinical depression and childhood trauma on withdrawal and abstinence outcomes among smokers with current depressive disorders, and the effect of psychiatric disorders on abstinence outcomes in cancer patients.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Behavioral Science, Division of Cancer Prevention and Population, University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1992 | Virginia Polytechnic Institute & State University, Blacksburg, VA, USA, Ph.D, Clinical Psychology |
| 1991 | Medical University of South Carolina, Charleston, SC, USA, Training, Internship, Psychology |
| 1987 | University of the Pacific, Stockton, CA, USA, MA, Psychology |
| 1980 | Southwest Texas State University, San Marcos, TX, USA, BS, Psychology |
Experience & Service
Administrative Appointments/Responsibilities
Assistant Director, Department of Tobacco Treatment Program, The University of Texas MD Anderson Cancer Center, Houston, 2005 - 2017
Selected Publications
Peer-Reviewed Articles
- Robinson JD, Karam-Hage M, Kypriotakis G, Beneventi D, Blalock JA, Cui Y, Gonzalez R, Tayar J, Chaftari P, Cinciripini PM. Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict 31(3):236-241, 2022. e-Pub 2022. PMID: 35347796.
- Cinciripini PM, Kypriotakis G, Green C, Lawrence D, Anthenelli RM, Minnix J, Blalock JA, Beneventi D, Morris C, Karam-Hage M. The Effects of Varenicline, Bupropion, Nicotine Patch and Placebo on Smoking Cessation among Smokers with Major Depression: A Randomized Clinical Trial. Depress Anxiety 39(5):1-12, 2022. PMID: 35535436.
- Salloum RG, Rojewski AM, Piper ME, Blalock JA, Borrelli B, Boyce LM, Minnix JA, Dogar O, Tomko RL, Jorenby DE, Kotsen C, Ostroff JS. Reporting Treatment Fidelity in Behavioral Tobacco Treatment Clinical Trials: Scoping Review and Measurement Recommendations. Nicotine Tob Res 24(2):150-159, 2022. e-Pub 2021. PMID: 34197617.
- Rodriguez-Cano R, Paulus DJ, Derrick JL, Blalock JA, Zvolensky MJ. Emotion dysregulation and hazardous drinking in relation to suicidal ideation among Spanish-speaking Latinx daily-smokers. J Subst Abuse Treat 132:108508, 2022. e-Pub 2021. PMID: 34098209.
- Cancer Center Cessation Initiative Implementation Science Working Group: Schnoll R, Chen L, Ramsey AT, Presant CA, Jose T, Ashing KT, Shelley D, Bernstein SL, Fleisher L, Salloum RG, Warren GW, Wiseman KP, Blalock JA, Dahl NA, Farka EB, Manders D, Ostroff JS, Park ER, Adsit R, Hohl SD, Minion M, Pauk D, Rolland B. Implementation science to improve tobacco cessation services in oncology care. J Natl Compr Canc Netw 19(Suppl_1):S12-S15, 2021. PMID: 34872048.
- Cox-Martin E, Cox MG, Basen-Engquist K, Bradley C, Blalock JA . Changing multiple health behaviors in cancer survivors: smoking and exercise. Psychol Health Med 25(3):1-13, 2020. e-Pub 2019. PMID: 31630537.
- Tamí-Maury I, Sharma A, Chen M, Blalock JA , Ortiz J, Weaver L, Shete S. Comparing smoking behavior between female-to-male and male-to-female transgender adults. Tob Prev Cessat 6:2, 2020. e-Pub 2020. PMID: 32548339.
- Cinciripini PM, Karam-Hage M, Kypriotakis G, Robinson JD, Rabius V, Beneventi D, Minnix JA, Blalock JA . Association of a comprehensive smoking cessation program with smoking abstinence among patients with cancer. JAMA Netw Open 2(9):e1912251, 2019. e-Pub 2019. PMID: 31560387.
- Minnix JA, Blalock JA, Karam-Hage M, Cinciripini PM. The importance of incorporating smoking cessation into lung cancer screening. Translational Lung Cancer Research 7(3):272-280, 2018. PMID: 30050765.
- Karam-Hage M, Kypriotakis G, Robinson JD, Green CE, Mann G, Rabius V, Wippold R, Blalock JA, Mouhayar E, Tayar J, Chaftari P, Cinciripini PM. Improvement of smoking abstinence Rates with increased Varenicline dosage: A propensity score-matched analysis. J Clin Psychopharmacol 38(1):34-41, 2018. PMID: 29232312.
- Cofta-Woerpel L, Lam C, Reitzel L, Wilson W, Karam-Hage M, Beneventi D, Cofer J, Baker E, WetterD, Cinciripini P, Blalock JA. A tele-mentoring tobacco cessation case consultation and education model for healthcare providers in community mental health centers. Cogent Medicine:5: 1430652, 2018. PMID: 30364535.
- Cox M, Basen-Engquist K, Carmack CL, Blalock JA, Li Y, Murray J, Pisters L, Rodriguez-Bigas M, Song J, Cox-Martin E**, Demark-Wahnefried W. Comparison of internet and telephone interventions for weight loss among cancer survivors: Randomized controlled trial and feasibility study. JMIR Cancer 3(2):e16, 2017. e-Pub 2017. PMID: 28954716.
- Karam-Hage M, Oughli HA, Rabius V, Beneventi D, Wippold RC, Blalock JA, Cinciripini PM. Tobacco cessation treatment pathways for patients with cancer: 10 years in the making. J Natl Compr Canc Netw 14(11):1469-1477, 2016. PMID: 27799514.
- Farris SG**, Robinson JD, Zvolensky MJ, Hogan J, Rabius V, Cinciripini PM, Karam-Hage M, Blalock JA. Panic attacks and smoking cessation among cancer patients receiving smoking cessation treatment. Addict Behav 61:32-9, 2016. e-Pub 2016. PMID: 27235990.
- Martin EC**, Basen-Engquist K, Cox MG, Lyons EJ, Carmack CL, Blalock JA, Demark-Wahnefried W. Interest in health behavior intervention delivery modalities among cancer survivors: A cross-sectional study. JMIR Cancer 2(1/e1):e1, 2016. e-Pub 2016. PMID: 28410164.
- Bluethmann SM, Basen-Engquist K, Vernon SW, Cox M, Gabriel KP, Stansberry SA, Carmack CL, Blalock JA, Demark-Wahnefried W. Grasping the 'teachable moment': time since diagnosis, symptom burden and health behaviors in breast, colorectal and prostate cancer survivors. Psychooncology 24(10):1250-1257, 2015. e-Pub 2015. PMID: 26060053.
- Parrott CE**, Rathnayaka N, Blalock JA, Minnix JA, Cinciripini PM, Vincent JP, Wetter DW, Green C. Examination of the Wisconsin inventory of smoking dependence motives (WISDM-68) factor structure in a sample of pregnant smokers. Nicotine Tob Res 17(6):653-60, 2015. e-Pub 2014. PMID: 25475086.
- Wippold R, Karam-Hage M, Blalock JA, Cinciripini P. Selection of optimal tobacco cessation medication treatment in patients with cancer. Clin J Oncol Nurs 19(2):170-5, 2015. PMID: 25840382.
- Stotts AL, Northrup TF, Cinciripini PM, Minnix JA, Blalock JA, Mullen PD, Pedroza C, Blackwell S. Randomized, controlled pilot trial of bupropion for pregnant smokers: Challenges and future directions. Am J Perinatol 32(4):351-6, 2015. e-Pub 2014. PMID: 25111040.
- Lin J, Blalock JA, Chen M, Ye Y, Gu J, Cohen L, Cinciripini PM, Wu X. Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients. Cancer Epidemiol Biomarkers Prev 24(2):336-43, 2015. e-Pub 2014. PMID: 25416716.
- |BFarris SG**, Zvolensky MJ, Blalock JA, Schmidt NB. Negative affect and smoking motives sequentially mediate the effect of panic attacks on tobacco-relevant processes. Am J Drug Alcohol Abuse 40(3):230-239, 2014. e-Pub 2014. PMID: 24720260.
- Mathew AR**, Robinson JD, Norton PJ, Cinciripini PM, Brown RA, Blalock JA. Affective trajectories before and after a quit attempt in smokers with current depressive disorders. Nicotine Tob Res 15(11):1807-1815, 2013. e-Pub 2013. PMID: 23509093.
- Blalock JA, Minnix JA, Mathew AR**, Wetter DW, McCullough JP, Cinciripini PM. Relationship of childhood trauma to depression and smoking outcomes in pregnant smokers. J Consult Clin Psychol 81(5):821-30, 2013. e-Pub 2013. PMID: 23750463.
- Blalock JA, Nayak N**, Wetter DW, Schreindorfer L**, Minnix JA, Canul J, Cinciripini PM. The relationship of childhood trauma to nicotine dependence in pregnant smokers. Psychol Addict Behav 25(4):652-63, 2011. e-Pub 2011. PMID: 21928869.
- Minnix JA, Blalock JA, Marani S, Prokhorov AV, Cinciripini PM. Self-efficacy mediates the effect of depression on smoking susceptibility in adolescents. Nicotine Tob Res 13(8):699-705, 2011. e-Pub 2011. PMID: 21482619.
- Blalock JA, Lam, CY, Minnix, JA, Karam-Hage, M, Gritz, ER, Robinson, JD, Cinciripini, PM. The effect of mood, anxiety and alcohol use disorders on smoking cessation in cancer patients. Journal of Cognitive Psychotherapy 25(1):82-96, 2011.
- Cinciripini PM, Blalock JA, Minnix JA, Robinson JD, Brown VL, Lam C, Wetter DW, Schreindorfer L, McCullough JP, Dolan-Mullen P, Stotts AL, Karam-Hage M. Effects of an intensive depression-focused intervention for smoking cessation in pregnancy. J Consult Clin Psychol 78(1):44-54, 2010. PMID: 20099949.
- Clague J, Cinciripini P, Blalock JA, Wu X, Hudmon KS. The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. Behav Genet 40(1):49-58, 2010. e-Pub 2009. PMID: 19842028.
- Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock JA, Wetter DW, Garden AS, Sturgis EM, Cinciripini PM. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer 115(19):4336-4344, 2009. PMID: 19569250.
Other Articles
- Almirall D, Blalock JA Summary of the SRNT treatment network Webinar: getting SMART about developing individualized sequences of health interventions. Nicotine Tob Res 16(2):252, 2014. PMID: 24302636.
Editorials
- Rabius V, Karam-Hage M, Blalock JA, Cinciripini PM. "Meaningful use" provides a meaningful opportunity. Cancer 120(4):464-468, 2014. PMID: 24496865.
Abstracts
- Lyons E, Basen-Engquist K, Blalock JA, Demark-Wahnefried W. Preferences of breast cancer survivors for traditional and new media delivery of health promotion interventions. Journal of Women’s Health 22(10):893-893, 2013.
- Basen-Engquist K, Carmack C, Blalock JA, Baum G, Rahming D, Demark-Wahnefried W.. Predictors of cancer survivors' receptivity to lifestyle behavior change interventions. Cancer Epidemiology, Biomarkers, and Prevention 21(3):559-560, 2012. e-Pub 2012.
Book Chapters
- Cofta-Woerpel, L, Lam C, Reitzel LR, Wilson W, Karam-Hage M, Beneventi D, Cofer J, Baker E, Wetter DW, Cinciripini PM, Blalock J. A Tele-mentoring tobacco cessation case consultation and education model for healthcare providers in community mental health centers. In: Prime Archives in Medicine. 2nd Edition. Vide Leaf Hyderabad: India, 2020.
Grant & Contract Support
| Title: | Enhanced tobacco cessation program for university students |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Optimizing the delivery of lifestyle interventions in cancer survivors |
| Funding Source: | MDACC-MRP |
| Role: | Project 3 Leader: Concurrent vs. sequential smoking and physical activity intervention for cancer survivors |
| Title: | A Phase 4, randomized, double-blind, active and placebo-controlled, multicenter study evaluating the neuropsychiatric safety and efficacy of 12 weeks varenicline tartrate 1 mg BID for smoking cessation in subjects with and without a history of psychiatric |
| Funding Source: | Pfizer Inc |
| Role: | Co-Investigator |
| Title: | Promoting long-term abstinence from smoking among cancer patients |
| Funding Source: | NIH |
| Role: | Co-Investigator |
| Title: | Postpartum intervention for pregnant smokers: Feasibility of smartphone delivery |
| Funding Source: | NIH/NIDA |
| Role: | Principal Investigator |
| Title: | Development of a transdiagnostic emotional vulnerability smoking cessation intervention for cancer patients |
| Funding Source: | Duncan Family Institute Seed-funding Research Program |
| Role: | Principal Investigator |
| Title: | Integrated care-versus quitline interventions for smokers with mental health conditions |
| Funding Source: | NIH/NCI |
| Role: | Multiple PI |
| Title: | ENDependence |
| Funding Source: | Arnold Foundation |
| Role: | Co-Investigator |
| Title: | Varenicline and combined NRT for initial smoking cessation and rescue treatment in smokers. A randomized pilot trial |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-Principal Investigator |
| Title: | Increasing access to smoking cessation and smoke free home services for low-income pregnant women in northeast Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Principal Investigator |
| Title: | Gender differences in Standard Research E-Cigarette (SREC) product use, acceptability, reinforcement, and nicotine dependence symptoms |
| Funding Source: | NIH/NIDA |
| Role: | Co-Investigator |
| Title: | CCSG supplement: DCPPS Expanding the reach of University of Texas MD Anderson Cancer Center Tobacco Treatment Program |
| Funding Source: | NIH/NCI |
| Role: | Program Leader |
| Title: | Optimizing Effectiveness of Smoking Cessation Invention During LDCT screening for Lung Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Expanding Tobacco Cessation in Northeast Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Principal Investigator |
| Title: | Pilot study to evaluate a behavioral activation prenatal and postpartum intervention for depressed pregnant smokers |
| Funding Source: | NIH/NIDA |
| Role: | Principal Investigator |
| Title: | Lung Moonshot adult cessation project |
| Funding Source: | Other |
| Role: | Co-Investigator |
| Title: | Cancer Control Moonshot platform proposal: Project TEACH |
| Funding Source: | MDACC |
| Role: | Co-Principal Investigator |
| Title: | Cancer Control Moonshot Platform Proposal: UT Dissemination |
| Funding Source: | |
| Role: | Principal Investigator |
| Title: | Innovative tobacco cessation intervention for oncology patients in Puerto Rico |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| Title: | Preliminary Effectiveness and Safety of Bupropion to Promote Smoking Cessation During Pregnancy |
| Funding Source: | The Center for Clinical and Translational Sciences (CCTS) |
| Role: | Co-Investigator |
| Title: | Administrative supplement to: Smoking cessation intervention for depressed smokers: Treatment development; entitled relationship of emotional reactivity to abstinence outcomes in smokers with current chronic depressive disorders |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator |
| Title: | Smoking cessation intervention for depressed smokers: Treatment development |
| Funding Source: | NIMH |
| Role: | Principal Investigator |
| Title: | Sub Contract to: Pre-surgical smoking cessation intervention in cancer |
| Funding Source: | NIDA |
| Role: | Co-Investigator |
| Title: | Developmental Project to 1 P50 CA91846: A study to evaluate the combination of scheduled smoking and Bupropion SR versus Bupropion SR alone for smoking cessation in bladder cancer patients |
| Funding Source: | NCI |
| Role: | Principal Investigator |
| Title: | A pilot study to evaluate a mood management smoking cessation intervention in depressed smokers |
| Funding Source: | The University of Texas M.D. Anderson Cancer Center |
| Role: | Principal Investigator |
| Title: | Genetic factors in the modulation of mood by nicotine |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Scheduled smoking with transdermal nicotine |
| Funding Source: | NIDA |
| Role: | Co-Investigator |
| Title: | Study 1: The relationship between a potential genetic marker (DRD2A1 Allele) of nicotine abuse liability to psychological and pharmacological measures of nicotine dependence. Study 2: Genetics, mood, and nicotine withdrawal |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |